Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a compound of formula I;
or a pharmaceutically acceptable salt thereof, wherein X is defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.
-
Citations
15 Claims
- 1. A compound of the formula (I):
Specification